BYETTA

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Ireland, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug BYETTA contains one active pharmaceutical ingredient (API):

1 Exenatide UNII 9P1872D4OL - EXENATIDE

Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that exhibits several antihyperglycaemic actions of glucagon-like peptide-1 (GLP-1). The amino acid sequence of exenatide partially overlaps that of human GLP-1. Exenatide has been shown to bind to and activate the known human GLP-1 receptor in vitro, its mechanism of action mediated by cyclic AMP and/or other intracellular signalling pathways. Exenatide increases, on a glucose-dependent basis, the secretion of insulin from pancreatic beta cells. Read about Exenatide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BYETTA Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BJ01	Exenatide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 3423E, 3424F
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502317100031717, 502317100031817, 505115010021304
Country: CA	Health Products and Food Branch	Identifier(s): 02361809, 02361817
Country: EE	Ravimiamet	Identifier(s): 1270437, 1270448, 1270459, 1270460
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 06362001, 06362003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 072978, 072996
Country: FR	Base de données publique des médicaments	Identifier(s): 60983726, 69937274
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 114949, 114956, 299809, 367636, 374327, 377165, 380743, 381237, 381239
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499411G1026, 2499411G2022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1005474, 1005475, 1027772, 1027774
Country: NL	Z-Index G-Standaard	Identifier(s): 15612511, 15990362
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 92916, 92932
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12288, 12298
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100173861, 100173878
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W61681001, W61681002, W61682001, W61682002
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699786951006, 8699786952003
Country: US	FDA, National Drug Code	Identifier(s): 0310-6512, 0310-6524
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/34/0068, 41/34/0069